|Bid||0.00 x 3100|
|Ask||12.00 x 3000|
|Day's Range||11.44 - 11.85|
|52 Week Range||7.99 - 14.10|
|Beta (5Y Monthly)||1.40|
|PE Ratio (TTM)||16.48|
|Earnings Date||Feb 11, 2021 - Feb 15, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.33|
FibroGen's (FGEN) Evrenzo (roxadustat) wins second approval in Japan for treating anemia caused by chronic kidney disease in non-dialysis-dependent patients.
Ironwood (IRWD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Matinas BioPharma (MTNB) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.